2020 Scientific Sessions

Intravenous Platelet Inhibition in PCI: Case-Based Look at Expanding Applications

This activity is supported by an unrestricted educational grant from Chiesi. No in-kind commercial support was received.
The Data for IV Platelet Inhibition in High-risk Patients: Which Patients Benefit the Most?
Roxana Mehran, M.D., MSCAI, Icahn School of Medicine at Mount Sinai, New York, NY
View Recording
COVID-19-Related Coagulopathies
Luis Gruberg, M.D., FSCAI, Southside Hospital, Setauket, NY
View Recording
IV Platelet Inhibition in Cardiogenic Shock: When to Use and for How Long?
Timothy D. Henry, M.D., MSCAI, The Christ Hospital Health Network, Covington, KY
View Recording
IV Antiplatelet Therapy in the ICU: A When-to-and-How-to Guide in the Era of COVID
Perwaiz M. Meraj, M.D., FSCAI, Northwell Health North Shore University Hospital, Manhasset, NY
View Recording
Case with Panel Discussion: PCI in Complex Stable CAD
Matthew J. Price, MD, Scripps Clinic Medical Group, La Jolla, CA
View Recording
See more of: Satellite Sessions
<< Previous Satellite | Next Satellite >>